JY
GRTX

Jeff Yass’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Jeff Yass’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-286,180
Closed -$40.1K – 13520
2024
Q1 		$40.1K Buy
+286,180
New +$56.4K ﹤0.01% 11632
2023
Q4 		– Sell
-98,543
Closed -$17.3K – 13545
2023
Q3 		$17.3K Buy
98,543
+23,175
+31% +$28.8K ﹤0.01% 11636
2023
Q2 		$235K Buy
75,368
+61,360
+438% +$183K ﹤0.01% 9938
2023
Q1 		$35.9K Sell
14,008
-1,175
-8% -$2.42K ﹤0.01% 11839
2022
Q4 		$22.6K Sell
15,183
-10,893
-42% -$17.7K ﹤0.01% 11725
2022
Q3 		$45K Sell
26,076
-4,202
-14% -$5.94K ﹤0.01% 12275
2022
Q2 		$39K Sell
30,278
-29,546
-49% -$50.6K ﹤0.01% 12111
2022
Q1 		$142K Sell
59,824
-86,314
-59% -$225K ﹤0.01% 11612
2021
Q4 		$671K Buy
+146,138
New +$483K ﹤0.01% 8386

Other funds holding GRTX

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Jeff Yass's GRTX Position: Q2 2024 in Review

Jeff Yass sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 286,180 shares — an estimated $40.1K sold.

Jeff Yass first reported a position in GRTX in Q4 2021 and held it in 9 quarters. The position peaked at $671K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

  • Jeff Yass reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jeff Yass sold 286,180 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $40.1K.
  • Jeff Yass first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Jeff Yass's Galera Therapeutics, Inc. Common Stock position peaked at $671K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.